SM
IRWD icon

SG3 Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

SG3 Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,000
Closed -$129K – 1117
2021
Q2 		$129K Buy
+10,000
New +$114K ﹤0.01% 876
2020
Q4 		– Sell
-7,500
Closed -$82.1K – 1113
2020
Q3 		$67K Buy
+7,500
New +$74.5K ﹤0.01% 818

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SG3 Management's IRWD Position: Q3 2021 in Review

SG3 Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2021, closing a stake of 10,000 shares — an estimated $129K sold.

SG3 Management first reported a position in IRWD in Q3 2020 and held it in 2 quarters. The position peaked at $129K in Q2 2021. 227 funds tracked by Wall St. Rank hold IRWD as of Q3 2021.

  • SG3 Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • SG3 Management sold 10,000 Ironwood Pharmaceuticals shares in Q3 2021, an estimated $129K.
  • SG3 Management first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • SG3 Management's Ironwood Pharmaceuticals position peaked at $129K in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2021.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.